Nature Reviews Drug Discovery
ISSN 1474-1776 · Nature Portfolio · United Kingdom · active 1967–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Nature Reviews Drug Discovery a predatory journal?
Our screening does not flag Nature Reviews Drug Discovery. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Nature Reviews Drug Discovery indexed in Scopus or Web of Science?
Per our venue index, Nature Reviews Drug Discovery appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Nature Reviews Drug Discovery's impact?
Papers in Nature Reviews Drug Discovery are cited about 11.6 times each within two years of publication, and Scimago places it in Q1, with an h-index of 469. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Nature Reviews Drug Discovery open access?
We hold no reliable open-access classification for Nature Reviews Drug Discovery. Check the journal's own site for its access model and any article processing charge.